June 16, 2025
As GLP-1 medications become more prevalent for weight management and chronic disease, employers are facing rapidly rising health care costs and new challenges in supporting employee well-being. Understanding how to effectively manage these costs while still providing high-quality care has never been more important.
During this Partner Perspective, you’ll hear from Julia Hu, co-founder and CEO of Lark Health, and Lynn Rossetto, Pharm. D., the Head of Pharmacy Strategy at Lark Health.
Watch now to learn:
- How GLP-1 medications are driving measurable improvements in workforce health and long-term medical cost trends
- New opportunities for personalized, scalable and cost-effective chronic disease management through AI
- The benefits of combining the precision of AI with the empathy of human support for a balanced, holistic approach to health
To continue the conversation with Lark, contact [email protected].
Watch Now >
More Topics
Resource
Preventive Care
Primary Care
Chronic & Complex Conditions
This content is for members only. Already a member?
Login
Join today to gain access to member-only resources!
Learn More